Modular Medical research shows pump interest
Analysis based on 7 articles · First reported Jul 14, 2026 · Last updated Jul 14, 2026
The positive survey results may boost investor confidence in Modular Medical's market opportunity for the Pivot pump, potentially supporting the stock price. However, the event is a preliminary research announcement with no immediate revenue impact, so market reaction is likely muted.
Modular Medical, Inc. (NASDAQ:MODD) announced positive findings from a research initiative indicating that 97% of surveyed insulin injection users would consider pump therapy if it were easier to learn and improved outcomes. The company will present the findings and showcase its Pivot tubeless insulin patch pump at the ADCES Annual Conference in August 2026. Additionally, Modular Medical has engaged Thrivable for expanded research with 320 patients to refine commercialization strategy.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard